“Tumour-Specific Amplitude-Modulated RF EMFs Induce Differentiation of Hepatocellular Carcinoma via Targeting Cav3.2 T-Type Voltage-Gated Calcium Channels and Ca2+ Influx,” EBioMedicince, posted May 31, 2019.
The latest on using weak EMFs to treat liver cancer from Boris Pasche’s group. See also companion paper posted in the same journal on May 22. Both are open access. For more on this work, see our report from 2011 and later update.
